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Incremental value of the CT coronary
calcium score for the prediction of coronary
artery disease
Abstract Objectives: To validate pub-
lished prediction models for the pres-
ence of obstructive coronary artery
disease (CAD) in patients with new
onset stable typical or atypical angina
pectoris and to assess the incremental
value of the CT coronary calcium
score (CTCS). Methods: We searched
the literature for clinical prediction
rules for the diagnosis of obstructive
CAD, deﬁned as ≥50% stenosis in
at least one vessel on conventional
coronary angiography. Signiﬁcant
variables were re-analysed in our
dataset of 254 patients with logistic
regression. CTCS was subsequently
included in the models. The area
under the receiver operating charac-
teristic curve (AUC) was calculated
to assess diagnostic performance.
Results: Re-analysing the variables
used by Diamond & Forrester
yielded an AUC of 0.798, which
increased to 0.890 by adding CTCS.
For Pryor, Morise 1994, Morise 1997
and Shaw the AUC increased from
0.838 to 0.901, 0.831 to 0.899, 0.840
to 0.898 and 0.833 to 0.899. CTCS
signiﬁcantly improved model per-
formance in each model. Conclu-
sions: Validation demonstrated good
diagnostic performance across all
models. CTCS improves the predic-
tion of the presence of obstructive
CAD, independent of clinical predic-
tors, and should be considered in its
diagnostic work-up.
Keywords Coronaryarterydisease .
X-raycomputedtomography .
Coronarycalciumscoring . Logistic
models . Diagnosis
Introduction
The CT coronary calcium score (CTCS) is used in both
the diagnosis of coronary artery disease (CAD) [1–6] and
the prediction of cardiovascular events [7–13]. Although
substantial evidence is available on the incremental value
of CTCS in predicting future cardiovascular events and
mortality in asymptomatic individuals [10–13], the diag-
nostic value in symptomatic patients is less clear.
A meta-analysis revealed that the presence of coronary
calcium had a sensitivity and speciﬁcity of 98% and 40%,
respectively, in detecting signiﬁcant stenoses [8]. Further-
more, numerous studies have reported on the value of CTCS
inthepredictionoftheprobabilityofobstructiveCAD[1–4].
However,theincrementalvalue (i . e.inad di ti ontoal lk no wn
clinical predictors of CAD) of the CTCS as a continuous
predictor of prevalent obstructive CAD is less well studied.
The purpose of this study was to validate previously
published clinical prediction models and to determine the
incremental value of CTCS for the prediction of prevalent
obstructive CAD in patients with new onset stable typical
or atypical angina pectoris.
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Study population
The study population was derived from an existing
database, which consisted of 402 patients with chest pain
suggestive of stable angina pectoris and suspected of
having CAD. All patients were prospectively included in a
large study evaluating 64-slice CT coronary angiography
(CTCA) at our institution. All patients were referred for
conventional coronary angiography (CCA) based on their
presentation or functional testing that suggested the
presence of ischaemia and all patients underwent multi-
detector CT angiography within a week before CCA.
Inclusion criteria for this study were: informed consent,
sinus heart rhythm and the ability to hold their breath for
15 s. Patients with a history of percutaneous coronary
intervention or coronary artery bypass surgery, impaired
renal function (serum creatinine >120 μmol/L) or a known
intolerance to iodinated contrast medium were excluded.
The Institutional Review Board approved the study and all
patients signed informed consent. As this paper focuses on
patients with new onset stable chest pain, we also
excluded patients with acute coronary syndromes and
patients with a previous myocardial infarction (Fig. 1).
CT coronary calcium images
Metoprolol (100 mg, Selokeen, AstraZeneca, London,
UK) was administered orally 1 h before CT in patients
with heart rates >65 beats per minute. A 64-slice single
source CT system (Sensation 64; Siemens, Forchheim,
Germany) with a gantry rotation time of 330 ms,
acquisition time of 165 ms and voxel size of 0.4 mm
3
was used to acquire standard spiral low-dose and ECG-
gated coronary calcium CT images. CT parameters were
32×2 slices per rotation, individual detector width of
0.6 mm, 3.8-mm/rotation table feed, 120-kV tube voltage,
150-mAs tube current, with activated prospective x-ray
tube modulation. Overlapping slices were reconstructed at
65% of the R–R interval using the B35f convolution
kernel. Reconstructed slice thickness was 3.0 mm with an
increment of 1.5 mm. The radiation exposure, estimated
using dedicated software (ImPACT, version 0.99x, St.
George’s Hospital, Tooting, London, UK), was 1.4 mSv in
men and 1.8 mSv in women. One observer (with more
than 3 years’ experience), who was blinded to the CCA
and clinical data, measured the coronary calcium.
Conventional coronary angiography
The CTCS and CCA were carried out within 1 week.
Coronary segments were assessed on CCA following a
17-segment modiﬁed American Heart Association (AHA)
classiﬁcation model [14] by a single observer (with more
than 10 years’ experience), who was blinded to the CT
and clinical data. A mean luminal narrowing of ≥50% was
considered to be a signiﬁcant stenosis. Validated quanti-
tative coronary angiography software (CAAS II®, Pie
Medical, Maastricht, the Netherlands) was used.
Clinical variables and outcome
All patients were interviewed at enrollment in the prospec-
tive cohort study. Clinical parameters recorded were: age
(years), sex (male/female), type of chest pain (atypical vs.
typical), body mass index (BMI) (deﬁned as weight/height
2
in kg/m
2), smoking status (past or current smoker, yes/no),
hypertension (present/absent), dyslipidaemia (serum cho-
lesterol >200 mg/dL or 5.18 mmol/L, present/absent),
diabetes (plasma glucose ≥126 mg/dL or 7.0 mmol,
present/absent) and family history of CAD (present/absent).
The CTCS was measured by the Agatston method [15]
using dedicated software (syngo Calcium Scoring VE31H,
Siemens, Germany). The outcome of interest was the
presence of obstructive CAD deﬁned as ≥50% stenosis in
at least one vessel (present/absent) on CCA.
Sample size
As a general rule, 10 patients with the condition of interest
per analysed variable are required for regression analysis.
In our dataset (n=254), 123 patients were identiﬁed as
having obstructive CAD on CCA. This allowed for the
analysis of 12 variables. Our sample meets the required
number of cases and non-cases that has been suggested for
external validation of prediction models [16].
Systematic literature search
We searched the English-language medical literature in
PubMed up to October 14, 2009 for diagnostic prediction
Fig. 1 Flow chart of patients in the study. CTCA computed
tomography coronary angiography. *Data from an existing
database were used. All patients were referred for conventional
coronary angiography based on their presentation or functional
testing that suggested the presence of cardiac ischaemia. See
Materials and methods
2332models. See the Appendix for a detailed description of the
search strategy. From the included articles, clinical
variables that were identiﬁed as signiﬁcant predictors of
CAD were extracted.
Data analysis
Age was analysed as a continuous variable. To account for
the skewed distribution of the coronary calcium scoring,
CTCS was transformed by taking the natural logarithm of
CTCS+1. All other variables were dichotomous. Oestrogen
status was not available in our dataset. Therefore, we
assumed women below the age of 50 to be oestrogen
positive, women of 50 years and above to be oestrogen
negative and all men to be oestrogen neutral. Obesity was
considered in the model by Morise (1997) only. We deﬁned
obesity as a BMI >27 kg/m
2, corresponding to their
deﬁnition [17].
The extracted sets of clinical variables were analysed
with multivariate logistic regression analysis, ﬁtting new
regression coefﬁcients. No attempt was made to validate
original regression coefﬁcients, as such coefﬁcients were
often not reported. CTCS was subsequently included in
each of the models. Models without CTCS were compared
with corresponding models including CTCS using the
likelihood ratio test. The level of signiﬁcance was deﬁned
at a p value less than 0.05.
Diagnostic performance was assessed by calculating the
area under the receiver operating characteristic (ROC)
curve, the c-index. The c-index is a measure of discrim-
ination and is interpreted as being the probability that a
randomly chosen patient with CAD will have a higher
predicted probability of disease than a randomly chosen
patient without CAD [18]. An area under the ROC curve
(AUC) of 0.5 corresponds to a model that provides no
diagnostic information, whereas an AUC of 1.0 corre-
sponds to a perfect diagnostic model.
STATA statistical analysis software v10.0 (StataCorp,
Texas, USA) was used for logistic regression analysis.
Next, we quantiﬁed the effect of adding CTCS to the
model on the classiﬁcation of patients into probability
categories of CAD. Four probability categories were
deﬁned: <30%, Q30–50%, Q50–70% and Q70%. Reclassi-
ﬁcation tables were constructed for the Diamond &
Forrester model and the Pryor model (see Tables 4 and
5)[ 19]. We computed the reclassiﬁcation calibration
statistic (RCS) [20] which is equivalent to the Hosmer–
Lemeshow statistic, applied to the cross-classiﬁed cells of
the reclassiﬁcation table with at least 20 observations. A
signiﬁcant result indicates a lack of ﬁt.
Furthermore, the following reclassiﬁcation measures
were calculated for each model: the overall (correct)
percentage of reclassiﬁcation, the net reclassiﬁcation
improvement (NRI) [21] and the integrated discrimination
improvement (IDI) [20]. The NRI is the difference in
proportions reclassifying to higher and lower probability
categories among cases and non-cases. It is interpreted as
the percentage reclassiﬁed, adjusted for the reclassiﬁcation
direction. A signiﬁcant NRI indicates that classiﬁcation
improves when CTCS is included. The IDI compares the
difference in the average regression slope of cases and
non-cases among the models with and without CTCS. A
signiﬁcant IDI indicates that the new model performs
better in discriminating cases and non-cases.
Reclassiﬁcation computations were executed by using
syntax made available by Cook and Ridker [20] in SAS
Enterprise Guide v3 (SAS Inc, North Carolina, USA).
Results
Study population
During a 24-month period, 402 patients were enrolled.
Patients with acute coronary syndrome or a history of
myocardial infarction were excluded and 254 patients
were left for data analysis (Table 1). Of these, 123 (48%)
patients had obstructive CAD on CCA. CTCS ranged
from 0 to 3,839 with a median of 4 for patients without
obstructive CAD and a median of 337 for patients with
obstructive CAD. Of 131 patients without obstructive
CAD, 44 (33.6%) patients had no coronary calciﬁcation;
whereas of 123 patients diagnosed with obstructive CAD,
3 (2.4%) patients did not have any coronary calciﬁcation.
Systematic literature search
We obtained 649 articles in our literature search of which
632 articles were excluded based on title or abstract. After
excluding 11 articles based on the full text, 6 studies were
left for analysis.
Multivariate logistic regression analysis
Five published prediction rules were validated (Tables 2
and 3): Diamond & Forrester [22], Pryor et al. [23],
Morise et al. 1994 [24], Morise et al. 1997 [17] and Shaw
et al. [25]. The Diamond & Forrester prediction rule
includes age, sex and type of chest pain, all of which were
signiﬁcant predictors of obstructive CAD in our dataset and
with an areaundertheROCcurve(AUC) of 0.798.Including
CTCS increased the AUC to 0.890, which was a statistically
signiﬁcant improvement (p<0.001). In the expanded model
age and sex were no longer signiﬁcant predictors (Table 2).
Pryor et al. analysed age, sex, type of chest pain,
smoking, dyslipidaemia, diabetes and the interaction
between age and smoking, age and dyslipidaemia, sex
and smoking, and age and sex, of which type of chest pain
and the presence of diabetes were signiﬁcant predictors.
This model resulted in an AUC of 0.838. After including
CTCS, the AUC increased to 0.901 which was a statisti-
cally signiﬁcant improvement (p<0.001). In the expanded
model diabetes was no longer a signiﬁcant predictor
(Table 2).
2333Morise et al. (1994) included diabetes and dyslipidae-
mia in addition to the variables used by Diamond &
Forrester and resulted in an AUC of 0.831. All variables
were signiﬁcant predictors of the presence of obstructive
CAD. After including CTCS, type of chest pain was the
only variable that remained signiﬁcant. After inclusion of
CTCS the AUC increased to 0.899, which was a statisti-
cally signiﬁcant improvement (p<0.001) (Table 2).
Morise et al. (1997) assessed age, sex, type of chest
pain, smoking, dyslipidaemia, diabetes, oestrogen status,
hypertension, family history, obesity, BMI and the
interaction between dyslipidaemia and family history.
This model resulted in an AUC of 0.840. Age, sex, type
of chest pain and dyslipidaemia were signiﬁcant predic-
tors. After including CTCS, the AUC increased to 0.898,
which was a signiﬁcant model improvement (p<0.001).
Age, sex and dyslipidaemia were no longer signiﬁcant
predictors after the addition of CTCS (Table 3).
Shaw et al. considered age, sex, typical chest pain,
smoking, dyslipidaemia and diabetes and resulted in an
AUC of 0.833. After including CTCS, only type of chest
pain remained a signiﬁcant predictor and the AUC
increased to 0.899 which was a statistically signiﬁcant
improvement (p<0.001) (Table 3).
Reclassiﬁcation tables for the Diamond & Forrester
model and the Pryor model are presented in Tables 4 and
5. The addition of CTCS to Diamond & Forrester resulted
in reclassiﬁcation of 47.2% of patients of whom 73.3%
were correctly reclassiﬁed. The reclassiﬁcation calibration
statistic (RCS) indicated a strong lack of ﬁt for the
Diamond & Forrester model (p<0.00001) which
decreased substantially when CTCS was added to the
model (p<0.01). The NRI (net reclassiﬁcation improve-
ment) was 33.6% (p<0.0001) and the IDI (integrated
discrimination improvement) was also statistically signiﬁ-
cant (18.8%, p<0.001) indicating improvement in the
classiﬁcation of cases and non-cases in probability
categories and improvement in discrimination between
cases and non-cases.
For the model by Pryor et al., 36.2% of the patients
were reclassiﬁed, of whom 54.3% were correctly classi-
ﬁed. The RCS indicated a lack of ﬁt( p=0.01), which
decreased when CTCS was added to the model (p=0.03).
The NRI was 24.0% (p<0.0001) and the IDI was 14.8%
(p<0.001).
The reclassiﬁcation measures for all models are
presented in Table 6.
Discussion
We analysed the incremental value of CTCS in the
prediction of prevalent obstructive CAD. We showed
CTCS to be a signiﬁcant predictor, independent of other
variables included in the model. Furthermore, we conﬁrm
that the prediction of prevalent obstructive CAD is mainly
determined by age, sex and type of chest pain.
In four of the ﬁve models age and sex were signiﬁcant
predictors before the addition of CTCS. However, after
including CTCS, both age and sex were no longer
signiﬁcant predictors in each of those models. Type of
chest pain was a signiﬁcant predictor of obstructive CAD,
independent of other variables included in the model and
independent of whether CTCS was included or not. CTCS
proved to be an excellent and signiﬁcant predictor of CAD
with adjusted odds ratios close to 2. Apart from age and
sex, most risk factors did not result in signiﬁcant odds
ratios which suggests that these risk factors are of minor
importance in the prediction of prevalent obstructive
CAD. Furthermore, the risk factors that were signiﬁcant
in the models without CTCS lost their signiﬁcance after
including CTCS.
Table 1 Patient characteristics
Total (n=254) no. Patients without CAD (n=131) no. Patients with CAD (n=123) no. p value
Mean age (SD) 59 (11) 56 (12) 62 (10) <0.001
Male sex (%) 171 (67%) 78 (60%) 93 (76%) 0.01
Typical chest pain (%) 118 (46%) 33 (25%) 85 (69%) < 0.001
Mean BMI
a (SD) 27 (4) 27 (4) 28 (5) 0.11
Smoking
b (%) 63 (25%) 30 (23%) 33 (27%) 0.47
Hypertension (%) 140 (55%) 59 (45%) 81 (66%) <0.001
Dyslipidaemia
c (%) 136 (54%) 47 (36%) 89 (72%) <0.001
Diabetes
d (%) 32 (13%) 10 (8%) 22 (18%) 0.01
Family history (%) 126 (50%) 57 (44%) 69 (56%) 0.05
Mean calcium score
e (SD) 346 (572) 132 (320) 574 (685) <0.001
Median calcium score 138 4 337 –
CAD
f on CCA (%) 123 (48%) 0 (0%) 123 (100%)
CAD obstructive coronary artery disease, CCA conventional coronary angiography, SD standard deviation
aBody Mass Index, deﬁned as weight/height
2 (in kg/m
2)
bPast or current
cSerum cholesterol >200 mg/dL or 5.18 mmol/L
dPlasma glucose ≥126 mg/dL or 7.0 mmol
eMeasured according to Agatston [15]
fDeﬁned as ≥50% stenosis in at least one vessel
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2335Analysis of reclassiﬁcation showed that adding CTCS
yields reclassiﬁcation of 34–47% of patients, most of
which was correct. The reclassiﬁcation calibration statistic
demonstrated a lack of ﬁt for all models, which decreased
when CTCS was added in all models except for Shaw’s.
Numerous studies have previously reported on the
incremental value of CTCS in the prediction of cardio-
vascular events and mortality in asymptomatic individuals
[10–13]. Some studies have reported on the incremental
value of CTCS in the prediction of prevalent obstructive
CAD.
Both Guerci et al. [1] and Kennedy et al. [2] studied the
relationship between obstructive CAD and CTCS, adjust-
ing for various risk factors. Both studies found highly
signiﬁcant odds ratios for the CTCS in predicting the
presence of obstructive CAD, but the odds ratios were
lower compared to what we found. Budoff et al. [4]
evaluated the value of CTCS in diagnosing CAD and
showed that the addition of CTCS increased the AUC
from 0.672 to 0.842. However, the models included only
ageandsexasclinicalvariables.Consideringthefactthatthe
type of chest pain was not taken into account, an increase in
Table 3 Comparison of multivariate logistic regression models
Variables Model 4: Morise et al. 1997 Model 5: Shaw et al. 1998
No calcium score Calcium score No calcium score Calcium score
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
ln CTCS
a (CT calcium score) 1.87 1.50, 2.31 1.86 1.51, 2.30
Intercept
Age 1.05 1.01, 1.09 0.99 0.95, 1.03 1.05 1.02, 1.08 0.98 0.95, 1.02
Male sex 3.15 1.29, 7.70 1.37 0.48, 3.95 3.42 1.74, 6.74 2.05 0.94, 4.45
Typical pain 5.56 2.94, 10.51 4.82 2.36, 9.86 5.50 2.96, 10.21 4.91 2.44, 9.90
Smoking 1.53 0.72, 3.24 1.03 0.44, 2.39 1.63 0.80, 3.30 1.04 0.47, 2.27
Dyslipidaemia 3.20 1.29, 7.95 1.80 0.62, 5.22 3.04 1.63, 5.66 1.95 0.96, 3.94
Diabetes 2.66 0.98, 7.26 2.01 0.61, 6.61 2.85 1.10, 7.39 2.24 0.74, 6.75
Age–smoking
Age–dyslipidaemia
Sex–smoking
Age–sex
Oestrogen 0.78 0.33, 1.86 0.53 0.19, 1.48
Hypertension 1.83 0.93, 3.60 1.31 0.62, 2.79
Family History 2.02 0.77, 5.29 1.14 0.38, 3.39
Dyslipidaemia–family history 0.74 0.21, 2.60 1.15 0.28, 4.82
Obesity 0.88 0.31, 2.48 0.65 0.20, 2.12
BMI 0.99 0.88, 1.13 1.05 0.91, 1.22
AUC
b 0.840 0.792, 0.889 0.898 0.859, 0.936 0.833 0.783, 0.883 0.899 0.861, 0.937
LR test
c p<0.001 p<0.001
Odds ratios (ORs) in bold typeface are statistically signiﬁcant
aNatural logarithm of CTCS+1
bArea under the receiver operating characteristic curve
cLikelihood ratio test comparing model without CTCS and model including CTCS
Table 4 Probability of coronary artery disease: reclassiﬁcation table after addition of CTCS to the Diamond and Forrester (model 1)
Probability category based on model 1 Probability category based on model 1 + CTCS Total, n (%)
<30% Q30–50% Q50–70% Q70%
<30%
N (%) 51 (67.1) 19 (25.0%) 4 (5.2) 2 (2.6) 76 (29.9)
Observed probability, % 11.8 36.8 50.0 100.0 22.4
Q30–50%
N (%) 25 (39.7) 13 (20.6) 19 (30.2) 6 (9.5) 63 (28.4)
Observed probability, % 0.0 23.1 68.4 50.0 30.2
Q50–70%
N (%) 4 (11.1) 5 (13.9) 6 (16.7) 21 (58.3) 36 (14.2)
Observed probability, % 25 80.0 50.0 66.7 61.1
Q70%
N (%) 5 (6.3) 2 (2.5) 8 (10.1) 64 (81.0) 79 (31.1)
Observed probability, % 0.0 50.0 37.5 95.3 82.3
Total
N (%) 85 (33.5) 39 (15.4) 37 (14.6) 93 (36.6) 254 (100.0)
Observed probability, % 8.2 38.5 56.8 86.0 48.4
CTCS computed tomography coronary calcium score
2336AUC with CTCS can be expected. However, the resulting
area under the ROC curve for the model including CTCS
was similar to what we found. Schmermund et al. [3]
previously studied the value of CTCS in predicting the
extent of CAD. They showed an independent and incre-
mental value for CTCS in multiple linear regression in
predicting the total number of segments per patient with
≥50% stenosis.
Study limitations
Our study assessed the prediction of ≥50% stenosis in at
least one vessel. One could argue that physicians are
primarily interested in diagnosing severe CAD, as these
patients would be eligible for revascularisation whereas
others can be adequately treated medically. Likewise,
physicians might be primarily interested in predicting
future cardiovascular adverse events. However, we did not
consider prognosis in this analysis.
All patients in our study were referred for CCA based
on their presentation or functional testing that suggested
the presence of cardiac ischaemia. In this way a high-risk
population was selected, which could have biased our
results. Unfortunately this limitation is inherent to the
study design. Further research is necessary to determine
the value of CTCS in other (e.g. lower risk) populations.
Also, risk factors such as type of chest pain, smoking
status and family history of CAD were obtained by
interviewing the patient. Potentially, this method under-
estimates their predictive effects as compared to the
predictive effect of the CTCS, which was directly measured.
Tables 4 and 5 illustrate how CTCS inﬂuences the
classiﬁcation of patients in probability categories. How-
ever, the limitations of reclassiﬁcation measures in the
context of this research should be taken into account. Our
sample size was too small to reliably assess reclassiﬁca-
tion. For example, the RCS only uses the cross-classiﬁed
cells containing at least 20 observations. In Table 4 only
four cells contain 20 or more observations, implying that a
substantial amount of (correctly) reclassiﬁed patients are
ignored. Thus, in our study the reclassiﬁcation percen-
tages, NRI and IDI indices are more reliable than the RCS.
Ideally, the probability categories should be based on
clinically relevant cutoffs. However, no well-established
clinically relevant probability threshold exists. The prob-
ability of CAD is commonly deﬁned as low (<30%),
intermediate (Q30–70%) and high (Q70%) [26]. In our
view the intermediate category is rather wide, which is why
we divided this category into low–intermediate (Q30–50%)
and intermediate–high (Q50–70%). It should be noted that
the overall percentage of reclassiﬁcation is highly dependent
on the choice and number of probability categories.
Clinical implications
Our results demonstrate that the estimation of the
probability of obstructive CAD can be improved by
including CTCS. This implies that clinicians can make
better decisions as to whether a particular patient would
beneﬁt from further testing, for example CTCA or CCA. In
low-risk patients, a CTCS of 0 could exclude CAD and
avoid further testing using CTCA. Hereby, one also avoids
the intravenous administration of contrast agent, the extra
radiation exposure, and extra scan time and costs associated
with CTCA. In patients with a low CTCS, CCA can be
avoided and further non-invasive testing would be preferred.
InpatientswithanintermediateCTCS,aCTCAmightbethe
optimal next step. In patients with a high CTCS, direct CCA
might be justiﬁed because of the high probability of CAD.
All in all, CTCS could be useful as a triage test for patients
who are suspected of having CAD.
We conﬁrmed that the prediction of signiﬁcant CAD is
primarily driven by the patient’s symptoms. A detailed
history of the patient’s symptoms remains most important
in the diagnostic work-up of patients with suspected CAD.
However, history taking is difﬁcult and subjective, there-
Table 5 Probability of coronary artery disease: reclassiﬁcation table after addition of CTCS to the model published by Pryor et al.
(model 2)
Probability category based on model 2 Probability category based on model 2 + CTCS Total, n (%)
<30% Q30–50% Q50–70% Q70%
<30%
N (%) 76 (85.4) 10 (11.2) 2 (2.3) 1 (1.1) 89 (35.0)
Observed probability, % 9.2 40.0 100.0 100.0 15.7
Q30–50%
N (%) 10 (27.0) 10 (27.0) 12 (32.4) 5 (13.5) 37 (14.6)
Observed probability, % 10.0 20.0 50.0 100.0 37.8
Q50–70%
N (%) 7 (13.5) 6 (11.5) 15 (28.9) 24 (46.2) 52 (20.5)
Observed probability, % 0.0 50.0 73.3 66.7 57.7
Q70%
N (%) 3 (4.0) 3 (4.0) 9 (11.8) 61 (80.3) 76 (29.9)
Observed probability, % 33.3 0.0 66.7 95.0 85.5
Total
N (%) 96 (37.8) 29 (11.4) 38 (15.0) 91 (35.8) 254 (100.0)
Observed probability, % 9.4 31.0 65.8 87.9 48.4
CTCS computed tomography coronary calcium score
2337fore limiting our ability to accurately predict the presence
of CAD. Hence, further diagnostic testing will be
important, even in patients with a low to intermediate
probability of CAD.
On the other hand, the harms and costs of obtaining
CTCS shouldbeconsidered.Kim [27] studied theradiation
dose and cancer risk of CTCS screening (every 5 years) in
asymptomatic individuals. They concluded that the excess
lifetime cancer risk was 42 (62) per 100,000 men (women).
It is important to note that our study assessed the value of a
single CTCS in symptomatic patients, for whom the excess
lifetime cancer risk will be lower and small compared with
the risk of missing a CAD diagnosis. Moreover, CTCS
could reduce the use of additional testing in patients with a
low CTCS and a low probability of CAD, thereby reducing
the total radiation exposure.
Although performing a CTCS measurement is a fast, low-
dose and relatively inexpensive procedure, the harms and
beneﬁts should be considered in a cost-effectiveness analysis.
Conclusion
Our results suggest that CTCS signiﬁcantly improves the
prediction of prevalent obstructive CAD, independent of
other clinical variables. Therefore, CTCS should be
considered in the diagnostic work-up of CAD.
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Appendix
Studies were included if they met all of the following
criteria: (1) Study population were patients with chest pain
suggestive of stable angina pectoris, (2) study reported a
new multivariate prediction rule that included clinical
variables, (3) outcome was the presence of signiﬁcant
CAD deﬁned as ≥50% stenosis in at least one vessel.
Studies were excluded if they met one of the following
criteria: (1) Article was a review, guideline, or cost-
effectiveness analysis, or (2) study did not report a
prediction model, or (3) the outcome of interest was
prognostic (e.g. event rate after treatment) or the authors
did not use ≥50% stenosis in at least one vessel as their
outcome, or (4) study population consisted of unstable
patients, asymptomatic patients, patients with known CAD
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2338or patients with a speciﬁc co-morbidity, or (5) main topic
was a diagnostic (imaging) test, or (6) a reference standard
other than conventional coronary angiography was used, or
(7) authors did not use the traditional classiﬁcation of typical
and atypical chest pain, or (8) the study focused on the
association between one particular risk factor and CAD.
Articles not accessible were excluded from the analysis.
Search strategy
1. Coronary artery disease [MeSH]
2. Coronary heart disease [MeSH]
3. Coronary stenosis [MeSH]
4. Coronary disease
5. #1 OR #2 OR 3# OR 4
6. Chest pain [MeSH]
7. Angina pectoris [MeSH]
8. Suspected [title/abstract]
9. #6 OR #7 OR #8
10. Logistic models [MeSH]
11. Probability [MeSH]
12. Risk [MeSH]
13. Models, statistical [MeSH]
14. ROC curve [MeSH]
15. #10 OR #11 OR #12 OR #13 OR #14
16. Medical history taking [MeSH]
17. Physical examination [MeSH]
18. Clinical [title/abstract]
19. #16 OR #17 OR #18
20. #5 AND #9 AND #15 AND #19
21. Animals [MeSH] NOT humans [MeSH]
22. Editorial [publication type]
23. Comment [publication type]
24. Letter [publication type]
25. Meta-analysis [publication type]
26. Case reports [publication type])
27. #22 OR #23 OR #24 OR #25 OR #26
28. Acute [title/abstract]
29. #20 NOT #21 NOT #27 NOT #28
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